STOCK TITAN

Manhattan Associates Inc Financials

MANH
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Manhattan Associates Inc (MANH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MANH FY2025

Asset-light software economics let incremental revenue turn into cash fast, funding large buybacks while keeping liquidity intact.

FY2025 free cash flow reached $374M against $220M of net income because this model needs little reinvestment, so accounting profit converts into spendable cash unusually well. Over recent years, operating margin climbed from 22.6% to 25.9% while capital spending stayed modest, showing the business is extracting more earnings from each added sales dollar rather than merely getting bigger.

Gross margin expansion from 54.8% to 56.3% alongside rising R&D and SG&A means the margin lift did not come from cutting muscle; the company kept investing while still improving profitability. That points to a more favorable revenue mix and better fixed-cost absorption, not just simple cost restraint.

Equity stays lean because financing outflows are dominated by repurchases, not because operations are short of cash: the company still held $329M of cash with a current ratio of 1.3x. Liabilities sit above equity, but the cash build and steady liquidity make that look more like a buyback-shaped capital structure than an operating funding problem.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 68 / 100
Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Manhattan Associates Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
91

Manhattan Associates Inc has an operating margin of 25.9%, meaning the company retains $26 of operating profit per $100 of revenue. This strong profitability earns a score of 91/100, reflecting efficient cost management and pricing power. This is up from 25.1% the prior year.

Growth
60

Manhattan Associates Inc's revenue grew a modest 3.7% year-over-year to $1.1B. This slow but positive growth earns a score of 60/100.

Leverage
34

Manhattan Associates Inc has a moderate D/E ratio of 1.67. This balance of debt and equity financing earns a leverage score of 34/100.

Liquidity
32

Manhattan Associates Inc's current ratio of 1.28 indicates adequate short-term liquidity, earning a score of 32/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
95

Manhattan Associates Inc converts 34.6% of revenue into free cash flow ($374.0M). This strong cash generation earns a score of 95/100.

Returns
95

Manhattan Associates Inc earns a strong 69.9% return on equity (ROE), meaning it generates $70 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 95/100. This is down from 73.0% the prior year.

Altman Z-Score Safe
13.41

Manhattan Associates Inc scores 13.41, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($9.0B) relative to total liabilities ($524.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Manhattan Associates Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.77x

For every $1 of reported earnings, Manhattan Associates Inc generates $1.77 in operating cash flow ($389.5M OCF vs $219.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
63.8x

Manhattan Associates Inc earns $63.8 in operating income for every $1 of interest expense ($279.8M vs $4.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.1B
YoY+3.7%
5Y CAGR+13.0%
10Y CAGR+23.5%

Manhattan Associates Inc generated $1.1B in revenue in fiscal year 2025. This represents an increase of 3.7% from the prior year.

EBITDA
$286.1M
YoY+6.8%
5Y CAGR+18.4%
10Y CAGR+5.4%

Manhattan Associates Inc's EBITDA was $286.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 6.8% from the prior year.

Net Income
$219.9M
YoY+0.7%
5Y CAGR+20.3%
10Y CAGR+7.8%

Manhattan Associates Inc reported $219.9M in net income in fiscal year 2025. This represents an increase of 0.7% from the prior year.

EPS (Diluted)
$3.60
YoY+2.6%
5Y CAGR+21.5%
10Y CAGR+9.9%

Manhattan Associates Inc earned $3.60 per diluted share (EPS) in fiscal year 2025. This represents an increase of 2.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$374.0M
YoY+30.6%
5Y CAGR+22.0%
10Y CAGR+13.2%

Manhattan Associates Inc generated $374.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 30.6% from the prior year.

Cash & Debt
$328.7M
YoY+23.5%
5Y CAGR+9.9%
10Y CAGR+10.8%

Manhattan Associates Inc held $328.7M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
60M
YoY-2.1%
5Y CAGR-1.3%
10Y CAGR-2.0%

Manhattan Associates Inc had 60M shares outstanding in fiscal year 2025. This represents a decrease of 2.1% from the prior year.

Margins & Returns

Gross Margin
56.3%
YoY+1.5pp
5Y CAGR+2.4pp
10Y CAGR+135.6pp

Manhattan Associates Inc's gross margin was 56.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the prior year.

Operating Margin
25.9%
YoY+0.8pp
5Y CAGR+6.4pp
10Y CAGR-97.1pp

Manhattan Associates Inc's operating margin was 25.9% in fiscal year 2025, reflecting core business profitability. This is up 0.8 percentage points from the prior year.

Net Margin
20.3%
YoY-0.6pp
5Y CAGR+5.5pp
10Y CAGR-58.5pp

Manhattan Associates Inc's net profit margin was 20.3% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.6 percentage points from the prior year.

Return on Equity
69.9%
YoY-3.1pp
5Y CAGR+30.0pp
10Y CAGR+16.9pp

Manhattan Associates Inc's ROE was 69.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 3.1 percentage points from the prior year.

Capital Allocation

R&D Spending
$145.1M
YoY+5.4%
5Y CAGR+11.5%
10Y CAGR+10.4%

Manhattan Associates Inc invested $145.1M in research and development in fiscal year 2025. This represents an increase of 5.4% from the prior year.

Share Buybacks
$315.2M
YoY+10.1%
5Y CAGR+48.6%
10Y CAGR+10.9%

Manhattan Associates Inc spent $315.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 10.1% from the prior year.

Capital Expenditures
$15.5M
YoY+78.2%
5Y CAGR+41.4%
10Y CAGR+3.0%

Manhattan Associates Inc invested $15.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 78.2% from the prior year.

MANH Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $282.2M+4.4% $270.4M-2.0% $275.8M+1.2% $272.4M+3.7% $262.8M+2.7% $255.8M-4.1% $266.7M+0.5% $265.3M
Cost of Revenue $126.6M+4.0% $121.7M+1.6% $119.8M+3.1% $116.2M+1.4% $114.6M+1.4% $113.0M-4.8% $118.7M-1.2% $120.0M
Gross Profit $155.6M+4.7% $148.6M-4.7% $156.0M-0.1% $156.2M+5.4% $148.2M+3.8% $142.8M-3.5% $148.0M+1.9% $145.3M
R&D Expenses $37.3M-3.1% $38.5M+6.0% $36.4M+4.3% $34.9M-1.2% $35.3M+7.0% $33.0M-3.9% $34.3M-2.8% $35.3M
SG&A Expenses $23.7M+21.6% $19.5M-19.1% $24.1M-7.3% $26.0M+7.3% $24.2M-10.9% $27.2M+33.9% $20.3M-3.8% $21.1M
Operating Income $64.9M-3.1% $67.0M-11.6% $75.8M+2.8% $73.8M+16.8% $63.2M+4.1% $60.7M-19.2% $75.1M+10.1% $68.2M
Interest Expense $951K-33.4% $1.4M+41.9% $1.0M+18.2% $852K-22.6% $1.1M-25.4% $1.5M-9.8% $1.6M+8.8% $1.5M
Income Tax $20.0M+21.1% $16.5M-16.7% $19.8M+11.7% $17.7M+48.6% $11.9M-18.7% $14.7M+16.2% $12.6M-22.7% $16.3M
Net Income $49.3M-5.1% $52.0M-11.4% $58.6M+3.3% $56.8M+8.0% $52.6M+9.5% $48.0M-24.7% $63.8M+20.9% $52.8M
EPS (Diluted) $0.82 N/A $0.96+3.2% $0.93+9.4% $0.85 N/A $1.03+21.2% $0.85

MANH Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $740.5M-11.8% $839.4M+9.2% $768.8M+3.2% $744.7M+5.1% $708.2M-6.5% $757.6M+8.5% $698.1M+4.9% $665.3M
Current Assets $515.8M-11.6% $583.3M+10.9% $525.8M+8.8% $483.3M+6.2% $455.3M-9.5% $503.3M+11.3% $452.3M+6.1% $426.1M
Cash & Equivalents $226.1M-31.2% $328.7M+24.7% $263.6M+14.3% $230.6M+12.0% $205.9M-22.7% $266.2M+23.9% $215.0M+6.0% $202.7M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable $227.1M+5.8% $214.7M-2.2% $219.6M+4.6% $209.8M-0.4% $210.7M+2.5% $205.5M+2.9% $199.8M+4.5% $191.2M
Goodwill $62.2M0.0% $62.2M0.0% $62.2M0.0% $62.2M0.0% $62.2M0.0% $62.2M0.0% $62.2M0.0% $62.2M
Total Liabilities $535.4M+2.0% $524.6M+14.1% $459.6M-1.4% $465.9M+0.6% $463.1M+1.0% $458.4M+9.1% $420.2M-1.1% $424.7M
Current Liabilities $467.4M+2.5% $455.9M+13.9% $400.4M-1.7% $407.2M+0.5% $405.0M+1.2% $400.3M+10.5% $362.2M-0.1% $362.7M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $205.2M-34.8% $314.8M+1.8% $309.2M+10.9% $278.8M+13.7% $245.1M-18.1% $299.1M+7.6% $278.0M+15.5% $240.6M
Retained Earnings $240.6M-30.3% $345.1M+1.9% $338.7M+11.2% $304.5M+11.1% $274.1M-16.8% $329.4M+8.6% $303.4M+13.3% $267.8M

MANH Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $84.0M-42.8% $147.1M+57.9% $93.1M+25.7% $74.0M-1.6% $75.3M-28.1% $104.7M+68.1% $62.3M-15.0% $73.3M
Capital Expenditures $4.1M-11.9% $4.7M-21.4% $5.9M+48.9% $4.0M+346.7% $891K-71.5% $3.1M+210.0% $1.0M-54.5% $2.2M
Free Cash Flow $79.9M-43.9% $142.4M+63.3% $87.2M+24.4% $70.1M-5.8% $74.4M-26.8% $101.6M+65.7% $61.3M-13.7% $71.0M
Investing Cash Flow -$4.1M+11.9% -$4.7M+21.4% -$5.9M-48.9% -$4.0M-346.7% -$891K+71.5% -$3.1M-210.0% -$1.0M+54.5% -$2.2M
Financing Cash Flow -$179.4M-133.0% -$77.0M-49.3% -$51.5M-2.7% -$50.2M+63.2% -$136.4M-201.8% -$45.2M+12.4% -$51.6M+31.8% -$75.7M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $179.4M+133.0% $77.0M+49.3% $51.5M+2.7% $50.2M-63.2% $136.4M+201.8% $45.2M-12.4% $51.6M-31.8% $75.7M

MANH Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 55.1%+0.2pp 55.0%-1.6pp 56.6%-0.8pp 57.3%+0.9pp 56.4%+0.6pp 55.8%+0.3pp 55.5%+0.7pp 54.8%
Operating Margin 23.0%-1.8pp 24.8%-2.7pp 27.5%+0.4pp 27.1%+3.0pp 24.0%+0.3pp 23.7%-4.4pp 28.2%+2.5pp 25.7%
Net Margin 17.5%-1.7pp 19.2%-2.1pp 21.3%+0.4pp 20.8%+0.8pp 20.0%+1.2pp 18.8%-5.1pp 23.9%+4.0pp 19.9%
Return on Equity 24.0%+7.5pp 16.5%-2.4pp 19.0%-1.4pp 20.4%-1.1pp 21.4%+5.4pp 16.1%-6.9pp 22.9%+1.0pp 21.9%
Return on Assets 6.7%+0.5pp 6.2%-1.4pp 7.6%+0.0pp 7.6%+0.2pp 7.4%+1.1pp 6.3%-2.8pp 9.1%+1.2pp 7.9%
Current Ratio 1.10-0.2 1.28-0.0 1.31+0.1 1.19+0.1 1.12-0.1 1.260.0 1.25+0.1 1.17
Debt-to-Equity 2.61+0.9 1.67+0.2 1.49-0.2 1.67-0.2 1.89+0.4 1.53+0.0 1.51-0.3 1.76
FCF Margin 28.3%-24.3pp 52.7%+21.0pp 31.6%+5.9pp 25.7%-2.6pp 28.3%-11.4pp 39.7%+16.7pp 23.0%-3.8pp 26.8%

Similar Companies

Frequently Asked Questions

Manhattan Associates Inc (MANH) reported $1.1B in total revenue for fiscal year 2025. This represents a 3.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Manhattan Associates Inc (MANH) revenue grew by 3.7% year-over-year, from $1.0B to $1.1B in fiscal year 2025.

Yes, Manhattan Associates Inc (MANH) reported a net income of $219.9M in fiscal year 2025, with a net profit margin of 20.3%.

Manhattan Associates Inc (MANH) reported diluted earnings per share of $3.60 for fiscal year 2025. This represents a 2.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Manhattan Associates Inc (MANH) had EBITDA of $286.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Manhattan Associates Inc (MANH) had a gross margin of 56.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Manhattan Associates Inc (MANH) had an operating margin of 25.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Manhattan Associates Inc (MANH) had a net profit margin of 20.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Manhattan Associates Inc (MANH) has a return on equity of 69.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Manhattan Associates Inc (MANH) generated $374.0M in free cash flow during fiscal year 2025. This represents a 30.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Manhattan Associates Inc (MANH) generated $389.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Manhattan Associates Inc (MANH) had $839.4M in total assets as of fiscal year 2025, including both current and long-term assets.

Manhattan Associates Inc (MANH) invested $15.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Manhattan Associates Inc (MANH) invested $145.1M in research and development during fiscal year 2025.

Yes, Manhattan Associates Inc (MANH) spent $315.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Manhattan Associates Inc (MANH) had 60M shares outstanding as of fiscal year 2025.

Manhattan Associates Inc (MANH) had a current ratio of 1.28 as of fiscal year 2025, which is considered adequate.

Manhattan Associates Inc (MANH) had a debt-to-equity ratio of 1.67 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Manhattan Associates Inc (MANH) had a return on assets of 26.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Manhattan Associates Inc (MANH) has an Altman Z-Score of 13.41, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Manhattan Associates Inc (MANH) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Manhattan Associates Inc (MANH) has an earnings quality ratio of 1.77x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Manhattan Associates Inc (MANH) has an interest coverage ratio of 63.8x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Manhattan Associates Inc (MANH) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top